We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
87 hedge funds and large institutions have $44M invested in GALENA BIOPHARMA INC COM in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
32% more capital invested
Capital invested by funds: $33.3M → $44M (+$10.7M)
17% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $3.52M
10% more funds holding
Funds holding: 79 → 87 (+8)
Holders
87
Holders Change
+8
Holders Change %
+10.13%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
32
Reduced
18
Closed
10
Calls
$4.13M
Puts
$3.52M
Net Calls
+$615K
Net Calls Change
+$1.42M
Top Buyers
Top Sellers
| 1 |
SIM
Spark Investment Management
New York
|
-$462K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$249K |
| 3 |
Millennium Management
New York
|
-$232K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$208K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$196K |
